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Objectives: To assess the feasibility of a 30-minute education session for patients with 20 
patellofemoral pain on levels of catastrophizing and kinesiophobia. 21 
Design:  Randomised feasibility study 22 
Setting:  Three sites within a single NHS Organisation in England.  23 
Participants: Thirty-one adult patients were screened for inclusion, resulting in twenty-four 24 
who had a clinical diagnosis of patellofemoral pain being randomised equally to either the 25 
intervention or control group.  26 
Intervention: Participants were randomised to either control or intervention conditions; both 27 
received standardized physiotherapy while the intervention/experimental group received a 30-28 
minute educational session addressing causes of pain, beliefs about noise that comes from the 29 
joint, the impact of the pain on activity, the influence of other family members’ experience 30 
and beliefs about knee pain.  Intervention participants were also given an education leaflet: 31 
‘Managing My Patellofemoral Pain’.   32 
Main outcomes: recruitment, retention, intervention fidelity. 33 
Patient reported outcome measures (PROMs): Knee injury and Osteoarthritis Outcome Score 34 
for patellofemoral pain and osteoarthritis (KOOS-PF), Pain Catastrophizing Scale (PCS) and 35 
Tampa Scale for Kinesiophobia (TSK). 36 
Results: The study was successful in recruiting and retaining participants and was delivered 37 
as intended.   In addition, sufficient clinical data were generated to calculate the required 38 
sample size for a future study of efficacy  39 
Conclusions: This study which featured a 30-minute education session targeting levels of 40 
catastrophizing and kinesiophobia is feasible and identified that the TSK may be the most 41 
appropriate PROMs for a future study of efficacy of this intervention. Allowing for a drop out 42 
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of 20% as identified in similar studies, 86 participants (per arm) in a two-arm study would be 43 
required for a traditional randomised controlled trial design.   44 
 45 
  46 
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Introduction  47 
Patellofemoral pain (PFP) is characterised by peri or retropatellar knee pain, which is 48 
reproduced upon activities of daily-living when there is load or stress on the patellofemoral 49 
joint such as when climbing stairs, squatting and sitting (1). The impact of PFP may extend to 50 
social engagements and participation in physical activities including sports and occupational 51 
tasks (2).   52 
One in five of the general population will have experienced PFP within the last year (3) and 53 
there is a poor prognosis with  91% reporting  pain and dysfunction four years post-diagnosis 54 
(4). Symptoms may persist for decades after their first onset; with estimates ranging from 16 55 
to 20 years (4-7), therefore it is appropriate to consider PFP can become a chronic 56 
musculoskeletal condition in some instances.  Forty to 57% of patients will experience 57 
unfavourable long-term outcomes despite receiving evidence-based treatments (2) including 58 
strengthening exercises, often prescribed to address biomechanical faults during activities (8, 59 
9).  A significant number of patients who have PFP have been found to have lower levels of 60 
strength in their quadriceps and gluteal muscles than individuals without PFP (10).  However,  61 
research by Selfe et al (2016) (11) identified  a subgroup of PFP patients, predominantly 62 
males with higher levels of hip abductor and quadriceps strength who were classed as 63 
‘strong’.  This might help to explain why some patients who receive evidence-based 64 
strengthening exercises continue to have poor outcomes. Similar to other chronic 65 
musculoskeletal conditions, chronic PFP is associated with high pain intensity, low quality-66 
of-life and increased risk of ceasing participation in sports (12).  The psychological impact of 67 
PFP (13) offers a challenge to the traditional biomedical approach to the management of PFP.   68 
The most recent Consensus Statement from the International Patellofemoral Pain Research 69 
Retreat (10) recommends a greater emphasis be placed on addressing psychosocial factors and 70 
pain sensitization.  71 
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Robertson et al (2017) (14) explored the beliefs of patients with PFP about crepitus and the 72 
impact of this on their behaviour.  The key emergent themes influencing behaviour were: 73 
patients’ beliefs that crepitus was damaging, the influence of others and avoiding the noise.  74 
Patients, with PFP have also been found to have higher levels of catastrophizing, 75 
kinesiophobia (15) and mental distress (16) than people without PFP. Smith et al (2017) (17) 76 
demonstrated,  the importance of understanding the significant negative effects of  living with 77 
PFP on peoples lifestyles and how it impacted on their well-being. The study highlighted the 78 
possibility that improved outcomes could potentially be achieved by supporting people living 79 
with PFP to overcome psychological barriers. 80 
Biopsychosocial interventions targeting catastrophizing and kinesiophobia are yet to be fully 81 
explored in patients with PFP.  Research from other chronic pain conditions suggest that 82 
focusing on reducing kinesiophobia might be promising as it is moderately associated with 83 
lower pain and higher function following appropriate education (15, 18). Similar to the 84 
traditional clinical management of PFP, the usual patient education approach for PFP is also 85 
through a biomedical lens where anatomy and biomechanics are the main foci (18).  However, 86 
pain is complex; it is a sensory and emotional experience (18, 19) which can have a longer 87 
term impact on behaviour (19).  Therefore, the intervention in this feasibility study adopted a 88 
biopsychosocial approach focussing on catastrophizing and kinesiophobia, whereby the 89 
participants own lived experience and beliefs were discussed in reference to how they manage 90 
and respond to their pain.   91 
 92 
Methods 93 
The primary aim of this study was to determine the feasibility of a RCT comparing 94 
standardised physiotherapy with an education intervention addressing patients’ 95 
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catastrophizing and kinesiophobia.  Both groups received the same standardized 96 
physiotherapy while the experimental group also received a 30-minute educational session 97 
addressing kinesiophobia and catastrophizing. The specific uncertainties for this study were 98 
recruitment, retention, intervention fidelity (20), which meant that a feasibility study in the 99 
first instance was appropriate.  Secondary objectives were to generate data that would inform 100 
a sample size calculation for a future study by collecting data from three different patient 101 
reported outcome measures (PROMs) (21).  102 
 103 
Study design and participants 104 
In this single site feasibility study, twenty-four patients were recruited via an NHS teaching 105 
hospital.  The study was approved by the North West – Liverpool Central Research Ethics 106 
Committee and HRA (18/NW/0725) and all participants provided written informed consent.  107 
The study was registered with Clinicaltrials.gov NCT03784339. 108 
Patients who had been clinically diagnosed in a Musculoskeletal Clinical Assessment Service 109 
(MCAS) with PFP at 3 sites within an NHS teaching hospital trust were approached to take 110 
part in the study. Recruitment began in April 2019, patients were provided with information 111 
about the study by a participant identification physiotherapist.  The research physiotherapist 112 
contacted patients interested in taking part to discuss and made arrangements to obtain 113 
informed consent as appropriate.  Once enrolled onto to the study, randomisation software 114 
(Research randomizer: randomizer.org) was used to allocate participants to either intervention 115 





Eligibility was assessed by the research physiotherapist prior to taking written informed 119 
consent.   120 
Inclusion criteria:   121 
• Adults aged 18-40 years  122 
•  Able to understand written and spoken English.  123 
• Clinical diagnosis of PFP (2) 124 
•  Able to attend for up-to 12 weeks of physiotherapy   125 
Exclusion criteria:  126 
• Patients who presented with referred pain from the spine or hip, or who had 127 
tibiofemoral pathology of any nature on the ipsilateral side. 128 
• A diagnosis of PFJ osteoarthritis as confirmed by x-ray or MRI.  129 
• Previous surgery to the symptomatic knee. 130 
 131 
Outcome Measures 132 
The PROMs used in this study were Knee injury and Osteoarthritis Outcome Score – 133 
Patellofemoral subscale (KOOS-PF)  (22, 23), Pain Catastrophising Scale (PCS) (24) and 134 
Tampa Scale of Kinesiophobia (TSK) (25). 135 
The KOOS-PF includes five subscales; Pain, other Symptoms, Function in daily living 136 
(ADL), Function in sport and recreation (Sport/Rec) and knee related Quality-of-life (QOL).   137 
It also includes the 11-item patellofemoral pain and osteoarthritis subscale, developed for use 138 
with PFP patients.  Items are scored 0-4; the sub-scales are calculated independently, and 139 
transformed to give a score from 0-100 with 0 indicating worse scores. The reported 140 
minimum clinically important change (MCIC) is 16 points (22).  141 
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The PCS is a 13-item questionnaire describing thoughts and feelings that individuals 142 
experience when they have pain.  Participants reflect on their pain experience and indicate one 143 
of the 13 thoughts or feelings perceived at the time of pain.  The scale ranges from 0-52, 144 
where 52 represents greatest catastrophic pain (24); scores greater than 24 being associated 145 
with higher pain ratings  (26).  The reported MCIC is 9 points for low back pain (27) 146 
The TSK is a 17 item questionnaire used to quantify fear of movement and re-injury due to 147 
movement and physical activity on a scale of 0-68, where 68 indicates greatest fear of re-148 
injury due to movement (25, 28).  A score of thirty seven has been suggested as the boundary 149 
for high and low fear (29). The reported MCIC is 4 points (30) 150 
 151 
Sample size 152 
The sample size was informed by previous research (17, 31, 32), suggesting a total of n=24 153 
participants (n=12 per group) would be required to answer the feasibility objectives.   154 
Therefore in this 2 arm randomised feasibility study each group comprised 12 participants. 155 
 156 
Baseline measures 157 
Participants were asked to self-report their baseline characteristics including age, sex, and 158 
duration of symptoms, which were collected alongside baseline PROMs: KOOS-PF, TSK and 159 




Study design 162 
Participants were randomised to either the intervention (n=12) or the control group (n=12).  163 
All participants in both groups received their treatment directly from the research 164 
physiotherapist only.  165 
Control Conditions 166 
Participants in the control group underwent standardised treatment, comprising an explanation 167 
of the diagnosis of PFP with a management plan and an individualised home exercise 168 
programme.   169 
Experimental conditions 170 
Participants in the experimental group (the intervention group) received the same intervention 171 
as participants in the control group plus an individual education session.  The individual 172 
education session, lasted for 30 minutes and allowed a two-way face-face conversation to take 173 
place between the research physiotherapist and  the  participant.  Topics covered in the 174 
education session were  175 
• The causes of pain 176 
• Beliefs about pain 177 
• Beliefs about noises from the joint  178 
• The impact of the pain on activity 179 
• The influence of other family members’ experience and beliefs about knee pain 180 
A patient education leaflet was also provided (33) as part of the intervention.  Following the 181 
intervention session, participants received the same standardised physiotherapy as control 182 





The study objectives were to assess recruitment, retention and intervention fidelity.  186 
Recruitment was assessed by keeping a log of all patients identified as having PFP by the 187 
clinicians in MCAS and the number of those who met the inclusion criteria by the research 188 
physiotherapist against the number of participants recruited to the study.    189 
 190 
Retention 191 
To optimise retention participants who were lost to follow up were telephoned and PROMs 192 
sent in the post with paid return envelopes enclosed. A log was kept of those who responded 193 
to telephone and PROMs. 194 
 195 
Intervention fidelity 196 
Self-assessment was used by the research physiotherapist to assess intervention fidelity (34).  197 
The study protocol was reviewed to check if the pre-defined topics were discussed and if 198 
intervention participants received the education leaflet.  199 
 200 
Results  201 




Recruitment  204 
 205 
As illustrated by the CONSORT diagram, thirty-one patients were screened; seven of whom 206 
were ineligible (n=1 did not speak English, n=2 had undergone previous knee surgery, n=4 207 
declined to participate).  The remaining twenty-four were recruited and consented from April 208 
to November 2019 at a rate of three per month.  209 
(Insert table 1 Baseline characteristics here). 210 
 211 
 212 
Mean age was higher in the intervention group and both groups had more females. Mean 213 
duration of symptoms was longer in the intervention group.  The group also had higher mean 214 
scores on PCS and TSK. As this was a randomised design, baseline characteristics were not 215 
analysed for significant differences.  This was because we already know that these would 216 
have arisen by chance. Furthermore this practice of analysing for baseline differences is 217 
actively discouraged in randomised designs (35). 218 
The average (mode) number of treatment sessions attended was three and four in the 219 
intervention and control group respectively. There were no specific or fixed number of 220 
treatment sessions predefined for both intervention and control group participants.   221 
 222 
Retention  223 
Nineteen out of the 24 participants were retained in the study.  One (female) was lost to 224 
follow-up in the intervention group, four (3 female and 1 male) were lost to follow-up in the 225 




Intervention Fidelity 228 
This self-audit identified that the intervention was delivered as planned, all pre-determined 229 
topics were covered in the intervention session (experimental conditions), and thus fidelity 230 
was 100% with every participant.  231 
 232 
Outcome measures 233 
All participants improved their scores on each of the three PROMs; KOOS-PF, TSK and PCS, 234 
except for one whose KOOS-PF score deteriorated.   Mean pre-intervention, post-intervention 235 
and change scores are presented for each outcome measure (table 2). 236 
(Insert Table 2 here) 237 
 238 
Pre and post-scores for each of the questionnaires for the intervention and control groups are 239 
shown in box plots in figures 2-4. Figure 2 shows that both groups improved their KOOS-PF 240 
scores, with the range being greater post-intervention in the intervention group. 241 
PCS scores in figure 3 shows reduced post-intervention scores in both of the groups, with the 242 
same pattern as the post-intervention KOOS-PF in the intervention group.  TSK scores in 243 
figure 4 demonstrated the same pattern, although the spread of the data was not as wide.  244 
Inspecting the raw data identified an outlier in the intervention group, which appears to be 245 
responsible for the large spread, as seen in figure 2.  The participant’s pre-intervention 246 
KOOS-PF score was 25.0, but this reduced to 9.09 which was contrary to the participant’s 247 
subjective report that her symptoms had improved prior to completing the questionnaire.  248 
Once this outlier was removed, the central tendency and distribution of the data was more 249 








Results including outlier 256 
(Insert figure 2 here) 257 
(Insert figure 3 here) 258 
(Insert figure 4 here) 259 
 
 
The time taken to complete the KOOS-PF was within the suggested time frame of 10 260 
minutes (23) with the TSK and PCS taking less than five minutes each.  Patients were 261 
able to complete the three questionnaires without assistance in 15 to 20 mins. 262 
 263 
Sample size calculation  264 
The data from the results for each of the outcome measures was used in the following 265 
equation (Equation 1).  This was used to determine the number of participants required 266 
for a larger study with α=0.05 and β=0.2 (36) to calculate sample size for a two arm  267 
efficacy study. 268 
(Insert equation 1 here) 269 
 270 
Post-intervention means and standard deviations for each of the outcome measures in 271 
each of the groups (table 2) were used in the equation.  The participant who was an 272 
outlier on KOOS-PF was included in all sample size calculations.  Each total sample 273 
size has been inflated to include a 20% drop out allowance: 274 
• KOOS-PF: 2124 275 
• PCS: 150  276 
• TSK: 172 277 
Although the dropout rate for this current study was slightly higher at 20.8%, a 20% 278 
drop out rate has been used in the sample size calculations as this is consistent with 279 
other PFP research.   280 
Discussion  281 
This randomised feasibility study achieved its primary objective by demonstrating that it 282 
 
 
would feasible to evaluate the intervention in a future study. Additionally, it also addressed 283 
the secondary objective and informed a series of sample size calculations for a future 284 
study by collecting data from three different patient reported outcome measures 285 
(PROMs) 286 
This study was necessary because research shows that patients diagnosed with PFP have 287 
elevated levels of kinesiophobia and catastrophizing (37), however the optimal treatment 288 
approach to influence these psychological factors has not been identified.   289 
Recruitment  290 
Prior to the study commencing, audit data suggested 104 patients would be eligible to 291 
participate over a 12-month period, with a recruitment rate of eight per month from 292 
three sites in one NHS hospital trust. However, participants were recruited at a slower 293 
rate of three per month.  294 
Recruitment to the study was conducted by participant identification physiotherapists in 295 
the MCAS service. Review of referrals to the study identified that more participants 296 
(n=16) were recruited by the most senior rather than the junior participant identification 297 
physiotherapists (n=8).  This was unexpected as there was a ratio of 1:4 for these staff 298 
groups. This might have been because junior clinicians were less confident in their 299 
diagnosis of PFP, as opposed to it being an issue of competence.  Research has 300 
identified that physiotherapists’ with one years’ experience are competent at diagnosing 301 
knee disorders (38), which is supported by this study where only three of the 31 302 
participants screened were ineligible, suggesting that the participant identification 303 
physiotherapists were competent.  Time management could have been an issue, with 304 
junior clinicians having less time available to discuss the study, again this is consistent 305 
with previous research, which identified that time can impact on recruitment into RCTs 306 
 
 
(39).  A potential solution would be to utilise research clinicians, who are experienced 307 
in screening patients and whose sole role is to recruit to research.   308 
 309 
Retention 310 
Five participants were lost to follow up (control n=4, intervention n=1), representing  311 
~20.8% of participants, which is similar to other studies (40).  312 
In this study, recruitment and retention may have been affected by the intervention 313 
being at one site only.  This was a pragmatic decision as the research physiotherapist 314 
was based there, but it did mean that only patients able and willing to travel could 315 
participate.  316 
Future studies are likely to have multiple physiotherapists delivering the intervention at 317 
different sites, or alternatively employ online or digital platforms.  Both of these 318 
strategies would reduce the burden on patients and might encourage their participation 319 
in research (37).  These strategies might then translate into enhanced recruitment and 320 
retention.  321 
If there is concern about slow recruitment and borderline retention, a future study could 322 
also use an adapted RCT design whereby an internal pilot with clear progression rules 323 
are used to assess if the study should continue onto a main trial, thereby ensuring the 324 
research is robust and resources are not wasted (41).   325 
 326 
Intervention fidelity 327 
Self-reflection of the intervention identified fidelity, with multiple sites, would continue 328 
to be ensured with ongoing training and monitoring within and between sites, this is 329 
particularly important if multiple clinicians deliver the intervention.  Another potential 330 
strategy to promote fidelity might include using treatment manuals (42) or video to 331 
 
 
deliver the intervention as it would ensure that every participant receives the same 332 
information regardless of the clinician.   This strategy has been used successfully to 333 
reduce maladaptive belief in adolescents with PFP (37), although, the results should be 334 
interpreted with caution as this study was underpowered. If videos are considered this 335 
should be done with caution to ensure that it does not change the intervention to the 336 
point that the findings of this feasibility study are compromised.   337 
Sample size for a future two arm efficacy study  338 
Alternative sample sizes for a future two arm efficacy study were calculated using each 339 
of the outcome measures using the post-intervention means and standard deviations; 340 
which resulted in different sample sizes for each measure.   341 
The MCIC for KOOS-PF is recommended as 16 (22).  In this study an average change 342 
greater than 16 was found in both the control and intervention groups respectively (19.3, 343 
16.5).  Removing the outlier’s scores increased the mean change in the intervention 344 
group to 19.8; this might indicate that some participants may struggle to complete the 345 
KOOS-PF. It should be made clear to participants that they must ask if there is anything 346 
that they do not understand with the research physiotherapist readily available. Using 347 
the KOOS-PF to calculate a sample size for a future study suggested 2124 participants 348 
would be needed. This would be a significant challenge in terms of recruitment even if a 349 
multicentre approach were to be conducted 350 
The PCS MCIC is reported to be 9 points (27).  In this study the average change for the 351 
control and intervention was -9.3 and -8.4 respectively demonstrating a greater change 352 
in the control group.  However the PCS MCIC for PFP has not been identified and the 353 
score of 9 was recommended for lower back pain patients (27).  354 
Scott et al (2014) (26) has stated that a high score for the PCS was considered to be 355 
greater than 24.  In this study the average pre-scores, 18.4-23.3 for PCS was considered 356 
 
 
at the low end; in which case the educational based intervention may have had less of an 357 
impact as there was less room for improvement in patients with PFP. This has 358 
implications when considering future suitability of this outcome as a primary outcome 359 
measure in a larger study. 360 
The TSK cut off point between individuals with high and low fear is 37 (29).  This 361 
study had a pre-score of 43.2 in the intervention and 39.9 for the control, placing both in 362 
the high fear grouping. There were 9 in the control group and 12 in the intervention 363 
group with pre-TSK scores of 37 or more.   364 
The average post-intervention change for the TSK score was -3.5 for the control and -365 
4.5 for the intervention.  Therefore, only the intervention group achieved the reported 366 
MCIC of 4 (30).  Priore et al (2019) (43) reported a change of -5.64 in TSK when using 367 
a knee brace with PFP participants, although this study was limited to 6 weeks.  The 368 
changes in the TSK scores are in line with those from this feasibility study.  Although 369 
this was a feasibility study and not powered to detect differences between the 2 groups 370 
the TSK was able to identify a clinically important change in the intervention group. 371 
In this study, the TSK appeared to be the most appropriate outcome tool for assessing 372 
the education session delivered to this patient population and yielded a suggested future 373 
sample size of 172 which with appropriate resourcing could be achievable through a 374 
multicentre study.   375 
 376 
Strengths and limitations 377 
Risk of bias 378 
There are inherent risks of bias in this study.  It was not possible to mask or blind 379 
participants to their group allocation due to the nature of the intervention and the 380 
 
 
outcome measures were also self-reported.  In addition, the research physiotherapist 381 
collected participants’ outcome data and delivered the intervention, which might also 382 
have introduced social desirability bias if participants felt compelled to report better 383 
outcomes than they were actually experiencing.  This could be mitigated by having 384 
sufficient funding to ensure the involvement of multiple research physiotherapists; e.g. 385 
one to deliver the intervention and one to assist in outcome data collection.  386 
Recruitment 387 
Recruitment was slower than anticipated, thus prolonging the duration of the study, 388 
however this finding was beneficial as it should provide a more realistic recruitment 389 
timescale for a future appropriately powered study.  390 
 391 
Retention 392 
The drop out from this study was consistent with similar studies which also had a 393 
dropout rate of 20% (44). Retention may have been impacted by participants’ ability to 394 
regularly attend the intervention site for treatment.  A future study should consider 395 
‘releasing’ participants back to the original site once they have completed the 396 
intervention to undergo usual care or the use of supportive digital technology. 397 
Greater involvement of patients with PFP as part of patient and public involvement 398 
(PPI) would be essential in taking the results of this study and refining the design for 399 
future research.  This is particularly important because it is likely that the PPI group 400 
would identify potential difficulties and solutions to the proposed design, which would 401 
have a positive impact. This is particularly important if multiple-centres are to be 402 
considered for an efficacy study, which would be pragmatic as the required sample size 403 
 
 
to assess efficacy is large, and would not be realistic to conduct in a timely fashion at 404 
one site only.   405 
 406 
Intervention fidelity 407 
A limitation of this study was that it was delivered solely by the research 408 
physiotherapist who was restricted to a satellite clinic and there were no resources 409 
available to fund an independent assessment of intervention fidelity.  Furthermore our 410 
fidelity assessment focused only on delivery and not other aspects of fidelity, such as 411 
receipt; ensuring participants understood the information provided in the intervention 412 
(experimental conditions), and enactment; whether or not the participant applies the 413 
information and knowledge they have acquired to their own lives (34).   However, the 414 
study protocol was pre-registered with Clinicaltrials.gov NCT03784339 was used to 415 
review if the intervention had been delivered as intended.  416 
 417 
Future research recommendations 418 
This feasibility study has answered some of the uncertainties around the feasibility of 419 
conducting this research. Following amendments highlighted from this study it should 420 
now be tested further in a pilot study, guided by the MRC framework (20) prior to a 421 
larger suitably powered study to assess efficacy.  An appropriately powered future study 422 
should endeavour to identify if the education session is effective across varying degrees 423 
of chronicity.  In this study the mean duration of pain was over 3 years in both the 424 
control and intervention groups.   425 
The control group in this study had a greater improvement in the KOOS-PF and PCS, 426 
but the intervention group had a greater improvement in the TSK.  Future studies should 427 
 
 
consider only including participants with high scores on the identified pre-intervention 428 
outcome measures, or at least analyse large data sets further to see if the intervention 429 
has a greater effect on patients with high TSK scores and thus supports the theoretical 430 
proposition for the mode of action of the intervention.  This would potentially 431 
demonstrate greater change in pre-post-intervention scores which would influence the 432 
sample size calculation.  Furthermore, Machlachlan’s (2017) (37) systematic review 433 
into the psychological features of PFP recommends subgrouping patients to guide 434 
treatment, as although there is emerging evidence of the   435 
benefits of subgrouping and targeted physical intervention (10, 45) (9 & 44)    it remains 436 
unknown if a similar approach would be useful for psychological features.   437 
The stated aims of this study were to; determine the feasibility of a future two arm 438 
efficacy RCT comparing standardised physiotherapy with an education intervention 439 
addressing patients’ catastrophizing and kinesiophobia.  A limitation of the study was 440 
that we did not include a specific outcome measure to identify levels of mental distress.  441 
However, the PCS has been found to have a significant degree of overlap, identified on 442 
correlation matrix, among all measures of emotional distress (24).  The secondary 443 
objectives were to generate and analyse clinical data from three different outcome 444 
measures to inform the appropriate sample size that would be required for such a future 445 
study. 446 
This study has demonstrated that a larger study would be feasible based on the findings.  447 
The TSK appears to be the most appropriate outcome tool and yielded a suggested 448 
future sample size of 172 patients. A future pilot RCT would benefit from the inclusion 449 
of strict progression criterion in view of the challenges associated with recruitment and 450 
retention. The study has achieved its secondary objectives of generating enough clinical 451 
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Figure 1 Consort flow diagram 582 
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Female 10 8 
Age (years) 28.9 (5.9) 24.8 (5.6) 
Pain Duration (months) 42.66 (59.00) 38.75 (33.09) 
KOOS-PF 47.1 (13.90) 47.2 (15.20) 
PCS 23.3 (12.82) 18.4 (11.55) 
TSK 43.2 (4.93) 39.9 (3.64) 
 587 
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Table 2 Pre, post and change scores for outcome measures: mean (standard deviation) 589 
and minimally clinically important change (MCIC) score. 590 
 Pre Post Change   MCIC 
KOOS-PF Intervention 47.1 (13.90) 63.6 (25.89) +16.5 (16) 16 
KOOS-PF Control 47.2 (15.20) 66.5 (16.70) +19.3 (16) 
PCS Intervention 23.3 (12.82) 14.8 (14.04) -8.4 (9) 9 
PCS Control 18.4 (11.55) 9.1 (7.75) -9.3 (9) 
TSK Intervention 43.2 (4.93) 38.7 (4.45) -4.5 (4) 4 
TSK Control 39.9 (3.64) 36.4 (5.31) -3.5 (4) 
 591 





Figure 2 Pre and post-intervention KOOS scores for each group 595 
 596 
Figure 3 Pre and post-intervention PCS scores for each group 597 
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Equation 1 Sample size calculation 601 
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